2023-10-03 |
2023-09-29 |
A
Achat
|
Fairmount Funds Management LLC
Administrateur non-exécutif
Large shareholder
|
24 670
+1.3%
13,63
336 252
USD
|
24 670
+1.3%
|
13,63
|
336 252
USD
|
|
2023-09-28 |
2023-09-26 |
A
Achat
|
Fairmount Funds Management LLC
Administrateur non-exécutif
Large shareholder
|
30 000
+1.6%
13,15
394 500
USD
|
30 000
+1.6%
|
13,15
|
394 500
USD
|
|
2023-09-25 |
2023-09-22 |
A
Achat
|
Randhawa Simrat
Chief Medical Officer
Dirigeant
|
2 000
+100.0%
13,20
26 400
USD
|
2 000
+100.0%
|
13,20
|
26 400
USD
|
|
2023-09-25 |
2023-09-21 |
A
Achat
|
Randhawa Simrat
Chief Medical Officer
Dirigeant
|
2 000
+inf%
13,20
26 400
USD
|
2 000
+inf%
|
13,20
|
26 400
USD
|
|
2023-09-21 |
2023-09-19 |
A
Achat
|
Fairmount Funds Management LLC
Administrateur non-exécutif
Large shareholder
|
30 000
+1.6%
13,20
396 000
USD
|
30 000
+1.6%
|
13,20
|
396 000
USD
|
|
2023-09-13 |
2023-09-13 |
A
Achat
|
Fairmount Funds Management LLC
Administrateur non-exécutif
Large shareholder
|
9 367
+0.5%
11,76
110 156
USD
|
9 367
+0.5%
|
11,76
|
110 156
USD
|
|
2023-09-13 |
2023-09-12 |
A
Achat
|
Fairmount Funds Management LLC
Administrateur non-exécutif
Large shareholder
|
14 887
+0.8%
10,85
161 524
USD
|
14 887
+0.8%
|
10,85
|
161 524
USD
|
|
2023-02-09 |
2023-02-08 |
V
Vente
|
Third Rock Ventures IV, L.P.
Large shareholder
|
1 500 000
-32.9%
0,82
1 230 000
USD
|
1 500 000
-32.9%
|
0,82
|
1 230 000
USD
|
|
2023-02-09 |
2023-02-07 |
V
Vente
|
Third Rock Ventures IV, L.P.
Large shareholder
|
2 200 000
-32.6%
0,83
1 826 000
USD
|
2 200 000
-32.6%
|
0,83
|
1 826 000
USD
|
|
2020-07-01 |
2020-06-29 |
A
Achat
|
Booth Bruce
Administrateur non-exécutif
|
1 250 000
+inf%
8,00
10 000 000
USD
|
1 250 000
+inf%
|
8,00
|
10 000 000
USD
|
|
2020-01-10 |
2020-01-10 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
11 200
-4.3%
15,25
170 800
USD
|
11 200
-4.3%
|
15,25
|
170 800
USD
|
|
2020-01-03 |
2020-01-02 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
2 800
-1.1%
15,10
42 280
USD
|
2 800
-1.1%
|
15,10
|
42 280
USD
|
|
2020-01-03 |
2020-01-02 |
VP
Vente planifiée
|
DAVIS JOHN C. JR
Chief Medical Officer
|
11 294
-57.6%
15,04
169 817
USD
|
11 294
-57.6%
|
15,04
|
169 817
USD
|
|
2019-12-26 |
2019-12-24 |
VP
Vente planifiée
|
ISACSON CHRISTINA K.
Chief Business Officer
|
4 463
-5.1%
16,01
71 453
USD
|
4 463
-5.1%
|
16,01
|
71 453
USD
|
|
2019-12-26 |
2019-12-24 |
VP
Vente planifiée
|
ZDRAVESKI ZORAN
See Remarks
|
7 902
-5.8%
16,00
126 432
USD
|
7 902
-5.8%
|
16,00
|
126 432
USD
|
|
2019-12-26 |
2019-12-23 |
VP
Vente planifiée
|
ZDRAVESKI ZORAN
See Remarks
|
4 181
-3.0%
16,03
67 021
USD
|
4 181
-3.0%
|
16,03
|
67 021
USD
|
|
2019-12-26 |
2019-12-23 |
VP
Vente planifiée
|
ISACSON CHRISTINA K.
Chief Business Officer
|
9 867
-10.1%
16,03
158 168
USD
|
9 867
-10.1%
|
16,03
|
158 168
USD
|
|
2019-12-23 |
2019-12-23 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
2 897
-1.1%
15,10
43 755
USD
|
2 897
-1.1%
|
15,10
|
43 755
USD
|
|
2019-12-20 |
2019-12-20 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
76 711
-22.2%
15,16
1 162 617
USD
|
76 711
-22.2%
|
15,16
|
1 162 617
USD
|
|
2019-12-20 |
2019-12-20 |
VP
Vente planifiée
|
DAVIS JOHN C. JR
Chief Medical Officer
|
919
-10.0%
15,00
13 785
USD
|
919
-10.0%
|
15,00
|
13 785
USD
|
|
2019-12-13 |
2019-12-10 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
4 392
-1.3%
15,10
66 319
USD
|
4 392
-1.3%
|
15,10
|
66 319
USD
|
|
2019-12-11 |
2019-12-10 |
VP
Vente planifiée
|
DAVIS JOHN C. JR
Chief Medical Officer
|
17 055
-67.3%
15,00
255 825
USD
|
17 055
-67.3%
|
15,00
|
255 825
USD
|
|
2019-12-11 |
2019-12-09 |
VP
Vente planifiée
|
DAVIS JOHN C. JR
Chief Medical Officer
|
4 614
-35.7%
15,00
69 210
USD
|
4 614
-35.7%
|
15,00
|
69 210
USD
|
|
2019-12-02 |
2019-12-02 |
V
Vente
|
COOKE MICHAEL P.
Chief Scientific Officer
|
2 500
-1.0%
13,21
33 036
USD
|
2 500
-1.0%
|
13,21
|
33 036
USD
|
|
2019-12-02 |
2019-12-02 |
V
Vente
|
COOKE MICHAEL P.
Chief Scientific Officer
|
1 373
-0.6%
13,31
18 279
USD
|
1 373
-0.6%
|
13,31
|
18 279
USD
|
|
2019-12-02 |
2019-12-02 |
V
Vente
|
COOKE MICHAEL P.
Chief Scientific Officer
|
3 627
-1.5%
12,74
46 205
USD
|
3 627
-1.5%
|
12,74
|
46 205
USD
|
|
2019-11-25 |
2019-11-20 |
V
Vente
|
COOKE MICHAEL P.
Chief Scientific Officer
|
5 000
-2.0%
12,00
60 000
USD
|
5 000
-2.0%
|
12,00
|
60 000
USD
|
|
2019-11-01 |
2019-11-01 |
V
Vente
|
COOKE MICHAEL P.
Chief Scientific Officer
|
5 000
-1.9%
10,67
53 334
USD
|
5 000
-1.9%
|
10,67
|
53 334
USD
|
|
2019-10-03 |
2019-10-01 |
V
Vente
|
COOKE MICHAEL P.
Chief Scientific Officer
|
5 000
-1.9%
10,01
50 064
USD
|
5 000
-1.9%
|
10,01
|
50 064
USD
|
|
2019-09-19 |
2019-09-19 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
1 656
-0.6%
12,00
19 872
USD
|
1 656
-0.6%
|
12,00
|
19 872
USD
|
|
2019-09-16 |
2019-09-12 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
844
-0.3%
12,00
10 128
USD
|
844
-0.3%
|
12,00
|
10 128
USD
|
|
2019-09-04 |
2019-09-03 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
5 000
-1.8%
10,11
50 531
USD
|
5 000
-1.8%
|
10,11
|
50 531
USD
|
|
2019-08-01 |
2019-08-01 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
2 500
-0.9%
13,41
33 523
USD
|
2 500
-0.9%
|
13,41
|
33 523
USD
|
|
2019-08-01 |
2019-08-01 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
5 000
-1.8%
13,42
67 109
USD
|
5 000
-1.8%
|
13,42
|
67 109
USD
|
|
2019-07-02 |
2019-07-01 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
2 500
-0.9%
14,42
36 051
USD
|
2 500
-0.9%
|
14,42
|
36 051
USD
|
|
2019-07-02 |
2019-07-01 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
5 000
-1.8%
14,39
71 933
USD
|
5 000
-1.8%
|
14,39
|
71 933
USD
|
|
2019-06-24 |
2019-06-21 |
VP
Vente planifiée
|
ISACSON CHRISTINA K.
Chief Business Officer
|
5 415
-5.2%
16,07
87 019
USD
|
5 415
-5.2%
|
16,07
|
87 019
USD
|
|
2019-06-24 |
2019-06-21 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
12 331
-3.4%
15,11
186 321
USD
|
12 331
-3.4%
|
15,11
|
186 321
USD
|
|
2019-06-24 |
2019-06-20 |
VP
Vente planifiée
|
GARDNER JASON
See Remarks
|
1 669
-0.5%
15,10
25 202
USD
|
1 669
-0.5%
|
15,10
|
25 202
USD
|
|
2019-06-18 |
2019-06-17 |
VP
Vente planifiée
|
COOKE MICHAEL P.
Chief Scientific Officer
|
7 500
-2.6%
13,90
104 267
USD
|
7 500
-2.6%
|
13,90
|
104 267
USD
|
|
2019-03-22 |
2019-03-20 |
V
Vente
|
Booth Bruce
|
14 245
-100.0%
17,86
254 416
USD
|
14 245
-100.0%
|
17,86
|
254 416
USD
|
|
2019-03-22 |
2019-03-20 |
V
Vente
|
Atlas Venture Fund X, L.P.
Large shareholder
|
14 245
-100.0%
17,86
254 416
USD
|
14 245
-100.0%
|
17,86
|
254 416
USD
|
|
2018-06-27 |
2018-06-25 |
A
Achat
|
GARDNER JASON
See Remarks
Administrateur exécutif
|
400
+0.1%
15,00
6 000
USD
|
400
+0.1%
|
15,00
|
6 000
USD
|
|
2018-06-27 |
2018-06-25 |
A
Achat
|
Scadden David
Administrateur non-exécutif
|
6 600
+3.0%
15,00
99 000
USD
|
6 600
+3.0%
|
15,00
|
99 000
USD
|
|